SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) $ in Thousands	12 Months Ended
	Mar. 30, 2024 USD ($) unit	Apr. 01, 2023 USD ($)	Apr. 02, 2022 USD ($)
Segment Reporting Information [Line Items]
Number of business units | unit	3
Net revenues by business unit	$ 1,290,340	$ 1,168,060	$ 968,066
Effect of exchange rates	(2,916)	(20,824)	4,319
Net revenues	1,309,055	1,168,660	993,196
Operating Income (Loss)	164,883	156,033	80,750
Effect of exchange rates	(1,971)	8,419	18,993
Amortization of acquired intangible assets	32,031	32,640	47,414
Amortization of fair value inventory step-up	(3,347)	0	0
Integration and transaction costs	11,249	(411)	21,604
Restructuring related costs	14,089	657	4,230
Restructuring related costs	(9,499)	(10,892)	(24,594)
Digital transformation costs	15,667	4,536	0
Write downs of certain in-process intangible assets and PCS2 related charges	5,095	(616)	5,732
MDR and IVDR costs	5,588	9,854	11,033
Litigation-related charges	(6,670)	(5,230)	(1,368)
Impairment of intangible assets	10,419	0	0
Gains on divestiture and sale of assets	2,000	382	9,603
Depreciation and amortization	97,215	93,307	97,747
Total long-lived assets	$ 311,362	310,885
Number of Reportable Segments | unit	3
Net revenues	$ 1,309,055	1,168,660	993,196
Service [Member]
Segment Reporting Information [Line Items]
Net revenues	21,631	21,424	20,811
Net revenues	21,605	20,044	20,533
United States
Segment Reporting Information [Line Items]
Net revenues	970,007	842,897	639,322
Total long-lived assets	246,473	251,812
Japan
Segment Reporting Information [Line Items]
Net revenues	58,087	61,295	75,562
Total long-lived assets	1,597	997
Europe
Segment Reporting Information [Line Items]
Net revenues	160,142	156,680	163,520
Total long-lived assets	15,310	14,587
Rest of Asia
Segment Reporting Information [Line Items]
Net revenues	107,536	104,135	110,802
Total long-lived assets	26,728	26,263
Other
Segment Reporting Information [Line Items]
Net revenues	13,283	3,653	3,990
Total long-lived assets	21,254	17,226
Plasma [Member]
Segment Reporting Information [Line Items]
Net revenues by business unit	565,399	500,489	351,945
Restructuring related costs	(1,050)	(1,385)	(7,906)
Depreciation and amortization	45,712	41,612	28,314
Total long-lived assets	211,121	202,075
Plasma [Member] | Plasma Products and Services
Segment Reporting Information [Line Items]
Net revenues	565,944	496,923	351,347
Blood Center [Member]
Segment Reporting Information [Line Items]
Net revenues by business unit	278,959	289,365	294,541
Restructuring related costs	(286)	(75)	(556)
Depreciation and amortization	13,391	13,927	32,489
Total long-lived assets	54,262	68,395
Blood Center [Member] | Blood Center Products and Services
Segment Reporting Information [Line Items]
Net revenues	276,144	279,962	298,512
Hospital [Member]
Segment Reporting Information [Line Items]
Net revenues by business unit	445,982	378,206	321,580
Restructuring related costs	(408)	(546)	(379)
Depreciation and amortization	38,112	37,768	36,944
Total long-lived assets	45,979	40,415
Hospital [Member] | Hospital Products and Services
Segment Reporting Information [Line Items]
Net revenues	445,362	371,731	322,804
Apheresis, Blood Center | Blood Center Products and Services
Segment Reporting Information [Line Items]
Net revenues	204,086	200,546	221,878
Whole Blood, Blood Center | Blood Center Products and Services
Segment Reporting Information [Line Items]
Net revenues	72,058	79,416	76,634
Interventional Technologies, Hospital | Hospital Products and Services
Segment Reporting Information [Line Items]
Net revenues	174,285	126,717	93,827
Hemostasis Management, Hospital | Hospital Products and Services
Segment Reporting Information [Line Items]
Net revenues	159,139	138,854	127,379
Other, Hopsital | Hospital Products and Services
Segment Reporting Information [Line Items]
Net revenues	111,938	106,160	101,598
Business Unit
Segment Reporting Information [Line Items]
Net revenues	1,287,450	1,148,616	972,663
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating Income (Loss)	603,524	565,103	449,605
Operating Segments [Member] | Plasma [Member]
Segment Reporting Information [Line Items]
Operating Income (Loss)	309,791	278,580	183,131
Operating Segments [Member] | Blood Center [Member]
Segment Reporting Information [Line Items]
Operating Income (Loss)	109,556	132,107	136,691
Operating Segments [Member] | Hospital [Member]
Segment Reporting Information [Line Items]
Operating Income (Loss)	184,177	154,416	129,783
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Other Expenses	$ 325,016	$ 355,089	$ 281,476